Abbott Laboratories (ABT +2.4%) trades higher after receiving FDA clearance to sell its...

|About: Abbott Laboratories (ABT)|By:, SA News Editor

Abbott Laboratories (ABT +2.4%) trades higher after receiving FDA clearance to sell its FreeStyle InsuLinx system for monitoring blood glucose levels. InsuLinx, which is already available for sale in Canada and several European countries, is the first glucose monitoring system from Abbott to feature a touchscreen and automated logbook.